Dr. Mikako Ogawa
My Social Links

Dr. Mikako Ogawa

Associate Professor
Hamamatsu University School of Medicine, Japan

Highest Degree
Ph.D. in Pharmaceutical Sciences from Kyoto University, Japan

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Nuclear Imaging
62%
Nanomedicine
90%
Atmospheric Biology
75%
Optical Imaging
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Ogawa. M., I.O. Umeda, M. Kosugi, A. Kawai and Y. Hamaya et al., 2014. Development of 111In-Labeled Liposomes for Vulnerable Atherosclerotic Plaque Imaging. J. Nucl. Med., 55: 115-120.
    CrossRef  |  Direct Link  |  
  2. Satomi, T., M. Ogawa, I. Mori, S. Ishino, K. Kubo, Y. Magata and T. Nishimoto, 2013. Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron Oxide. J. Nucl. Med., 54: 999-1004.
    CrossRef  |  Direct Link  |  
  3. Okada, H., Y. Ouchi, M. Ogawa, M. Futatsubashi and Y. Saito et al., 2013. Alterations in alpha4beta2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Brain, 136: 3004-3017.
    CrossRef  |  Direct Link  |  
  4. Longmire, M.R., M. Ogawa, P.L. Choyke and H. Kobayashi, 2013. Dendrimers as high relaxivity MR contrast agents. Wiley Interd. Rev. Nanomed Nanobiotechnol. in press. 10.1002/wnan.1250.
    CrossRef  |  Direct Link  |  
  5. Liu, J., M. Ogawa, T. Sakai, M. Takashima, S. Okazaki and Y. Magata, 2013. Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques. Ann. Nucl. Med., 27: 669-675.
    CrossRef  |  Direct Link  |  
  6. Kurabe, N., T. Hayasaka, M. Ogawa, N. Masaki and Y. Ide et al., 2013. Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4. Cancer Sci., 104: 1295-1302.
    CrossRef  |  Direct Link  |  
  7. Kojima, C., T. Suehiro, K. Watanabe, M. Ogawa and A. Fukuhara et al., 2013. Doxorubicin-conjugated dendrimer/collagen hybrid gels for metastasis-associated drug delivery systems. Acta Biomater, 9: 5673-5680.
    CrossRef  |  Direct Link  |  
  8. Ishino, S., M. Ogawa, I. Mori, S. Nishimura, S. Ikeda, T. Sugita, T. Oikawa, T. Horiguchi and Y. Magata, 2013. F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: F-FDG accumulates in foamy macrophages. Eur. J. Nucl. Med. Mol. Imaging., (in press) .
  9. Ogawa, M., S. Nakamura, Y. Saito, M. Kosugi and Y. Magata, 2012. What Can Be Seen by 18F-FDG PET in Atherosclerosis Imaging? The Effect of Foam Cell Formation on 18F-FDG Uptake to Macrophages In Vitro. J. Nucl. Med., 53: 55-58.
    CrossRef  |  Direct Link  |  
  10. Urano, Y., M. Sakabe, N. Kosaka, M. Ogawa and M. Mitsunaga et al., 2011. Rapid cancer detection by topically spraying a gamma-glutamyltranspeptidase-activated fluorescent probe. Sci. Transl. Med. 3: 110-119.
    CrossRef  |  Direct Link  |  
  11. Ueda, M., Y. Iida, T. Yoneyama, T. Kawai, M. Ogawa, Y. Magata and H. Saji, 2011. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects. Synapse, 65: 77-83.
    CrossRef  |  Direct Link  |  
  12. Mitsunaga, M., M. Ogawa, N. Kosaka, L.T. Rosenblum, P.L. Choyke and H. Kobayashi, 2011. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat. Med., 17 : 1685-1691.
    CrossRef  |  Direct Link  |  
  13. Longmire, M.R., Ogawa, M., P.L. Choyke and H. Kobayashi, 2011. Biologically optimized nanosized molecules and particles: more than just size. Bioconjug. Chem., 22: 993-1000.
    CrossRef  |  Direct Link  |  
  14. Kojima, C., B. Turkbey, M. Ogawa, M. Bernardo and C.A. Regino et al., 2011. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. Nanomedicine, 7: 1001-1008.
    CrossRef  |  Direct Link  |  
  15. Kobayashi, H., M.R. Longmire, M. Ogawa and P.L. Choyke, 2011. Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem. Soc. Rev., 40: 4626-4648.
    CrossRef  |  Direct Link  |  
  16. Ueda, M., Y. Iida, A. Tominaga, T. Yoneyama and M. Ogawa et al., 2010. Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects. Br. J. Pharmacol., 159: 1201-1210.
    CrossRef  |  Direct Link  |  
  17. Regino, C.A., M. Ogawa, R. Alford, K.J. Wong and N. Kosaka et al., 2010. Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis. J. Med. Chem., 53: 1579-1586.
    CrossRef  |  Direct Link  |  
  18. Ogawa, M., S. Nishiyama, H. Tsukada, K. Hatano and T. Fuchigami et al., 2010. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype. Nulc. Med. Biol., 37: 347-355.
    CrossRef  |  Direct Link  |  
  19. Ogawa, M., N. Kosaka, C.A. Regino, M. Mitsunaga, P.L. Choyke and H. Kobayashi, 2010. High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation. Mol. Biosyst., 6: 888-893.
    CrossRef  |  Direct Link  |  
  20. Ogawa, M., C.A. Regino, B. Marcelino, M. Williams and N. Kosaka et al., 2010. New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. Bioconjug. Chem., 21: 955-960.
    CrossRef  |  Direct Link  |  
  21. Kosaka, N., M. Ogawa, D.S. Paik, C.H. Paik, P.L. Choyke and H. Kobayashi, 2010. Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer. Cancer Sci., 101: 820-825.
    CrossRef  |  Direct Link  |  
  22. Kojima, C., Y. Umeda, M. Ogawa, A. Harada, Y. Magata, and K. Kono, 2010. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology, vol, 21: 245104 10.1088/0957-4484/21/24/245104.
    CrossRef  |  Direct Link  |  
  23. Kobayashi, H., M.R. Longmire, M. Ogawa, P.L. Choyke and S. Kawamoto, 2010. Multiplexed imaging in cancer diagnosis: Applications and future advances. Lancet Oncol., 11: 589-595.
    CrossRef  |  Direct Link  |  
  24. Fuchigami, T., H. Yamaguchi, M. Ogawa, L. Biao, M. Nakayama, M. Haratake and Y. Magata, 2010. Synthesis and biological evaluation of radio-iodinated benzimidazoles as SPECT imaging agents for NR2B subtype of NMDA receptor. Bioorg.Med. Chem., 18: 7497-7506.
    CrossRef  |  Direct Link  |  
  25. Bumb, A., C.A.S. Regino, M.R. Perkins, M. Bernardo and M. Ogawa et al., 2010. Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology, vol, 21: 175704 10.1088/0957-4484/21/17/175704.
    CrossRef  |  Direct Link  |  
  26. Alford, R., M. Ogawa, M. Hassan., A.H. Gandjbakhche, P.L. Choyke and H. Kobayashi, 2010. Fluorescence lifetime imaging of activatable target specific molecular probes. Contrast Media Mol. Imag., 5: 1-8.
    CrossRef  |  Direct Link  |  
  27. Turkbey, B., H. Kobayashi, M. Ogawa, M. Bernardo and P.L. Choyke, 2009. Imaging of tumor angiogenesis: functional or targeted? AJR Am. J. Roentgenol., 193: 304-313.
    Direct Link  |  
  28. Ogawa, M., N. Kosaka, P.L. Choyke and H. Kobayashi, 2009. H-type dimer formation of fluorophores: A mechanism for activatable, in vivo optical molecular imaging. ACS Chem. Biol., 4: 535-546.
    CrossRef  |  Direct Link  |  
  29. Ogawa, M., N. Kosaka, P.L. Choyke and H. Kobayashi, 2009. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res., 69: 1268-1272.
    Direct Link  |  
  30. Ogawa, M., N. Kosaka, M.R. Longmire, Y. Urano, P.L. Choyke and H. Kobayashi, 2009. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol. Pharm., 6: 386-395.
    CrossRef  |  Direct Link  |  
  31. Ogawa, M., Kosaka, N., P.L. Choyke and H. Kobayashi, 2009. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer. Biocon. Chem., 20: 147-154.
    CrossRef  |  Direct Link  |  
  32. Ogawa, M., H. Tsukada, K. Hatano, Y. Ouchi, H. Saji, and Y. Magata 2009. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT). Biol. Pharm. Bull., 32: 337-340.
    CrossRef  |  Direct Link  |  
  33. Ogawa, M., C.A. Regino, P.L. Choyke and H. Kobayashi, 2009. In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol. Cancer Ther., 8: 232-239.
    CrossRef  |  Direct Link  |  
  34. Ogawa, M., C.A. Regino, J. Seidel, M.V. Green and W. Xi et al., 2009. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Biocon. Chem., 20: 2177-2184.
    CrossRef  |  Direct Link  |  
  35. Lucarelli, R.T., M. Ogawa, N. Kosaka, B. Turkbey, H. Kobayashi, and P.L. Choyke, 2009. New approaches to lymphatic imaging. Lymphat. Res. Biol., 7: 205-214.
    Direct Link  |  
  36. Longmire, M., N. Kosaka, M. Ogawa, P.L. Choyke and H. Kobayashi, 2009. Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer. Cancer Sci., 100: 1099-1104.
    CrossRef  |  Direct Link  |  
  37. Kosaka, N., Ogawa, M., N. Sato, P.L. Choyke and H. Kobayashi, 2009. In vivo real-time, multicolor, quantum dot lymphatic imaging. J. Invest. Dermatol., 129: 2818-2822.
    CrossRef  |  Direct Link  |  
  38. Kosaka, N., M. Ogawa, P.L. Choyke, and H. Kobayashi, 2009. Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol., 5: 1501-1511.
    Direct Link  |  
  39. Kosaka, N., M. Ogawa, P.L. Choyke, N. Karassina and C. Corona et al., 2009. In vivo stable tumor-specific painting in various colors using dehalogenase-based protein-tag fluorescent ligands. Biocon. Chem., 20: 1367-1374.
    CrossRef  |  Direct Link  |  
  40. Kosaka, N., M. Ogawa, M.R. Longmire, P.L. Choyke and H. Kobayashi, 2009. Multi-targeted multi-color in vivo optical imaging in a model of disseminated peritoneal ovarian cancer. J. Biomed. Opt., Vol, 14: 014023 10.1117/1.3083449.
    CrossRef  |  Direct Link  |  
  41. Kobayashi, H., M. Ogawa, R. Alford, P.L. Choyke and Y. Urano, 2009. New strategies for fluorescent probe design in medical diagnostic imaging. Chem. Rev., 110: 2620-2640.
    CrossRef  |  Direct Link  |  
  42. Kobayashi, H., M. Ogawa, N. Kosaka, P.L. Choyke and Y. Urano, 2009. Multicolor imaging of lymphatic function with two nanomaterials: Quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomedicine, 4: 411-419.
    CrossRef  |  Direct Link  |  
  43. Fuchigami, T., T. Haradahira, N. Fujimoto, Y. Nojiri and T. Mukai et al., 2009. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors. Bioorg. Med. Chem., 17: 5665-5675.
    CrossRef  |  Direct Link  |  
  44. Alford, R., M. Ogawa, P.L. Choyke, and H. Kobayashi, 2009. Molecular probes for the in vivo imaging of cancer. Mol. Biosyst., 5: 1279-1291.
    CrossRef  |  Direct Link  |  
  45. Alford, R., H.M. Simpson, J. Duberman, G.C. Hill and M. Ogawa et al., 2009. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol. Imaging, 8: 341-354.
    Direct Link  |  
  46. Ueda, M., Y. Iida, Y. Kitamura, H. Kawashima, M. Ogawa, Y. Magata and H. Saji, 2008. 5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons. Brain, Res., 1199: 46-52.
    CrossRef  |  Direct Link  |  
  47. Sekimata, K., K. Hatano, M. Ogawa, J. Abe and Y. Magata et al., 2008. Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. Nucl., Med. Biol., 35: 327-334.
    CrossRef  |  Direct Link  |  
  48. Longmire, M.R., M. Ogawa, Y. Hama, N. Kosaka, C.A. Regino, P.L. Choyke and H. Kobayashi 2008. Determination of optimal rhodamine fluorophore for in vivo optical imaging. Bioconug. Chem. 19: 1735-1742.
    CrossRef  |  Direct Link  |  
  49. Ishino, S., T. Mukai, Y. Kuge, N. Kume and M. Ogawa et al., 2008. Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J. Nucl. Med., 49: 1677-1685.
    CrossRef  |  Direct Link  |  
  50. Fuchigami, T., T. Haradahira, N. Fujimoto, T. Okauchi and J. Maeda, et al., 2008. Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel Nucl. Med. Biol., 35: 203-212.
    CrossRef  |  Direct Link  |  
  51. Tajima, T., K. Hatano, M. Suzuki, M. Ogawa and Y. Sakiyama et al., 2007. Increased binding potential of [11C]raclopride during unilateral continuous microinjection of nicotine in rat striatum observed by positron emission tomography. Synapse, 61: 943-950.
    CrossRef  |  Direct Link  |  
  52. Ishino, S., T. Mukai, N. Kume, D. Asano and M. Ogawa et al., 2007. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability--analysis in hypercholesterolemic rabbits. Atherosclerosis., 195: 48-56.
    CrossRef  |  Direct Link  |  
  53. Ogawa, M., Y. Magata, T. Kato, K. Hatano and S. Ishino et al., 2006. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J. Nucl. Med., 47: 1845-1850.
    Direct Link  |  
  54. Ogawa, M., Y. Iida, M. Nakagawa, Y. Kuge and H. Kawashima et al., 2006. Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: Search for an imaging index suitable for the early detection of Alzheimer's disease. Nucl. Med. Biol., 33: 249-254.
    CrossRef  |  Direct Link  |  
  55. Ogawa, M., R. Tatsumi, M. Fujio, J. Katayama. and Y. Magata, 2006. Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent. Nucl. Med. Biol., 33: 311-316.
    CrossRef  |  Direct Link  |  
  56. Hosokawa, R., N. Kambara, M. Ohba, T. Mukai and M. Ogawa et al., 2006. A catheter-based intravascular radiation detector of vulnerable plaques. J. Nucl. Med., 47: 863-867.
    Direct Link  |  
  57. Ogawa, M., H. Watabe, N. Teramoto, Y. Miyake and T. Hayashi et al., 2005. Understanding of cerebral energy metabolism by dynamic living brain slice imaging system with [18F]FDG. Neurosci. Res., 52: 357-361.
    CrossRef  |  Direct Link  |  
  58. Ueda, M., Y. Iida, T. Mukai, M. Mamede and K. Ishizu et al., 2004. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects. Ann. Nucl. Med., 18: 337-344.
    Direct Link  |  
  59. Ohnishi, T., T. Hayashi, S. Okabe, I. Nonaka and H. Matsuda et al., 2004. Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys. Biol. Psychiat., 55: 484-489.
    CrossRef  |  Direct Link  |  
  60. Ogawa, M., S. Ishino, T. Mukai, D. Asano, and N. Teramoto et al., 2004. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J. Nucl. Med., 45: 1245-1250.
    Direct Link  |  
  61. Mukai, T., R. Nohara, M. Ogawa, S. Ishino and N. Kambara et al., 2004. A catheter-based radiation detector for endovascular detection of atheromatous plaques. Eur. J. Nucl. Med. Mol. Imaging., 31: 1299-1303.
    CrossRef  |  Direct Link  |  
  62. Iida, Y., M. Ogawa, M. Ueda, A. Tominaga and H. Kawashima et al., 2004. Evaluation of 5-11C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors. J. Nucl. Med., 45: 878-884.
    Direct Link  |  
  63. Takahata, K., S. Shimazu, F. Yoneda, M. Ogawa, Y. Iida and H. Saji, 2003. Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice. J. Neural. Transm., 110: 859-869.
    CrossRef  |  Direct Link  |  
  64. Saji, H., Y. Iida, H. Kawashima, M. Ogawa and Y. Kitamura et al., 2003. In vivo., imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography. Anal. Sci., 19: 67-71.
    CrossRef  |  Direct Link  |  
  65. Ogawa, M., K. Hatano, Y. Kawasumi, K. Ishiwata, K. Kawamura, S. Ozaki and K. Ito, 2003. Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl- 1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography. Nucl. Med. Biol., 30: 51-59.
    Direct Link  |  
  66. Ogawa, M., K. Hatano, S. Oishi, Y. Kawasumi, N. Fujii et al., 2003. Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta3 integrin related tumor imaging. Nucl. Med. Biol., 30: 1-9.
    Direct Link  |  
  67. Magata, Y., T. Temma, H. Iida, M. Ogawa and T. Mukai et al., 2003. Development of injectable O-15 oxygen and estimation of rat OEF. J. Cereb. Blood Flow Metab., 23: 671-676.
    CrossRef  |  Direct Link  |  
  68. Kudomi, N., C. Eunjoo, S. Yamamoto, H. Watabe and M.K. Kyeong et al., 2003. Development of a GSO detector assembly for a continuous blood sampling system. IEEE Trans. Nucl. Sci., 50: 70-73.
    CrossRef  |  Direct Link  |  
  69. Saji, H., M. Ogawa, M. Ueda, Y. Iida and Y. Magata et al., 2002. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors. Ann. Nucl. Med., 16: 189-200.
    CrossRef  |  Direct Link  |  
  70. Kiyono, Y., Y. Iida, H. Kawashima, M. Ogawa, N. Tamaki, H. Nishimura and H. Saji, 2002. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. J. Nucl. Med. Mol. Imaging., 29: 999-1005.
    CrossRef  |  Direct Link  |  
  71. Kiyono, Y., N. Kanegawa, H. Kawashima, Y. Iida and T. Kinoshita et al., 2002. Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging. Nucl. Med. Biol., 29: 679-684.
    Direct Link  |  
  72. Ogawa, M., K. Hatano, Y. Kawasumi, J. Wichmann and K. Ito, 2001. Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent. Nucl. Med. Biol., 28: 941-947.
    Direct Link  |